Real-time enrollment status for this mortality in sickle cell clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:29 PM UTC
| NCT Number | NCT05213572 |
| Recruiting Status | Recruiting |
| Condition | Mortality in Sickle Cell |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | July 13, 2026 (4 days ago) |
As of July 17, 2026: Clinical trial NCT05213572 is currently recruiting participants. This clinical trial study for mortality in sickle cell is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05213572 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05213572 was last updated 4 days ago (July 13, 2026). HelloStudys verifies this status automatically.